Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)
Close on Nov 17, 2026Market cap $81.09MP/E –Yield –
Lucid Diagnostics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lucid Diagnostics's operating cash flow for the twelve months ending Jun 30, 2026 was -$46.87M. For fiscal 2025 it was -$46.49M. The highest annual figure on record is -$5.63M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$46.49M | – |
| FY2024 | Dec 31, 2024 | -$44.14M | – |
| FY2023 | Dec 31, 2023 | -$32.82M | – |
| FY2022 | Dec 31, 2022 | -$29.69M | – |
| FY2021 | Dec 31, 2021 | -$17.67M | – |
| FY2020 | Dec 31, 2020 | -$5.63M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.30M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.58M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.87M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.94M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.12M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.26M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.88M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.68M | – |
See a number that looks wrong?